Loading clinical trials...
Loading clinical trials...
Studying the effects of Etanercept (an anti-Tumor Necrosis Factor alpha) on early Chronic Regional Pain Syndrome (CRPS). Our hypothesis is that Etanercept will improve patient symptoms if given in ear...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Stanford University
NCT07473635 · CRPS (Complex Regional Pain Syndromes), CRPS (Complex Regional Pain Syndrome) Type I, and more
NCT04767646 · CRPS (Complex Regional Pain Syndrome) Type I
NCT05212571 · Complex Regional Pain Syndromes, CRPS (Complex Regional Pain Syndromes)
NCT07170722 · Neuropathic Pain, Complex Regional Pain Syndromes (CRPS), and more
NCT06987747 · Complex Regional Pain Syndrome (CRPS)
Stanford University
Palo Alto, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions